Health · Full coverage
Hormone Patch Shortage Easing After Eight Months, Supply Expected Soon
How 2 Israeli newsrooms covered this story — translated into English and compared side by side.
100% center
Center 2
By יונתן דושניצקי
First reported by N12 · 4 hours ago
What happened
After an eight-month shortage of Evorel 50 hormone patches, a vital treatment for thousands of Israeli women, supplies are expected to return to shelves in the coming days. The scarcity has caused significant distress and treatment disruptions, but a large shipment has arrived, and further restocking is anticipated.
- 01Hormone patch shortage impacting thousands of Israeli women is ending.
- 02Evorel 50 patches are crucial for fertility, cancer risk reduction, and menopause.
- 03The eight-month scarcity caused widespread distress and treatment interruptions.
- 04A large shipment has arrived, with more expected to meet demand.
- 05Global demand and manufacturing complexities contributed to the shortage.
Summary translated & synthesized from the sources below by baba. Read each original for the full report.
Full coverage · 2 outlets
The same event, reported separately by each newsroom. Open a few to compare what each emphasizes — and what they leave out.
Related stories
Hormone Therapy Shortages Leave Israeli Women Without Menopause TreatmentAug 11, 2026European Drug Shortages Raise Concerns Over Potential Impact on Israel's SupplyAug 13, 2026Israeli Women Shift Toward Long-Acting Contraceptives Amid Stable Pill UseJul 26, 2026Asthma Patients in Israel Face Ventolin Shortage as GSK Halts Sales PermanentlyJul 21, 2026Menopause Becomes Major Focus of Health, Business and Public Discourse3 hours agoAbCellera’s Non-Hormonal Menopause Treatment Boosts Stock by 40% After Successful TrialAug 11, 2026
